Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry

Stölzl D, Boraczynski N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, Weisshaar E, Schäkel K, et al. (2022)
Experimental Dermatology 31(2): E39-E40.

Kurzbeitrag Konferenz / Poster | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Stölzl, Dora; Boraczynski, N.; Heratizadeh, Annice; Haufe, Eva; Harder, Inken; Abraham, Susanne; Heinrich, Luise; Kleinheinz, Andreas; Wollenberg, Andreas; Weisshaar, Elke; Schäkel, Kurt; Ertner, Konstantin
Alle
Erscheinungsjahr
2022
Serien- oder Zeitschriftentitel
Experimental Dermatology
Band
31
Ausgabe
2
Seite(n)
E39-E40
Konferenz
48th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF)
Konferenzort
online
Konferenzdatum
2022-02-23 – 2022-02-26
ISSN
0906-6705
eISSN
1600-0625
Page URI
https://pub.uni-bielefeld.de/record/2968760

Zitieren

Stölzl D, Boraczynski N, Heratizadeh A, et al. Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry. Experimental Dermatology. 2022;31(2):E39-E40.
Stölzl, D., Boraczynski, N., Heratizadeh, A., Haufe, E., Harder, I., Abraham, S., Heinrich, L., et al. (2022). Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry. Experimental Dermatology, 31(2), E39-E40.
Stölzl, Dora, Boraczynski, N., Heratizadeh, Annice, Haufe, Eva, Harder, Inken, Abraham, Susanne, Heinrich, Luise, et al. 2022. “Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry”, Experimental Dermatology, 31 (2): E39-E40.
Stölzl, D., Boraczynski, N., Heratizadeh, A., Haufe, E., Harder, I., Abraham, S., Heinrich, L., Kleinheinz, A., Wollenberg, A., Weisshaar, E., et al. (2022). Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry. Experimental Dermatology 31, E39-E40.
Stölzl, D., et al., 2022. Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry. Experimental Dermatology, 31(2), p E39-E40.
D. Stölzl, et al., “Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry”, Experimental Dermatology, vol. 31, 2022, pp. E39-E40.
Stölzl, D., Boraczynski, N., Heratizadeh, A., Haufe, E., Harder, I., Abraham, S., Heinrich, L., Kleinheinz, A., Wollenberg, A., Weisshaar, E., Schäkel, K., Ertner, K., Wiemers, F., Wildberger, J., Worm, M., von Kiedrowski, R., Effendy, I., Asmussen, A., Augustin, M., Pawlak, M., Sticherling, M., Zink, A., Hilgers, M., Handrick, C., Quist, S.R., Schwarz, B., Staubach-Renz, P., Bell, M., Hong-Weldemann, S.-H., Homey, B., Brücher, J.J., Schmitt, J., Werfel, T., Weidinger, S.: Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry. Experimental Dermatology. 31, E39-E40 (2022).
Stölzl, Dora, Boraczynski, N., Heratizadeh, Annice, Haufe, Eva, Harder, Inken, Abraham, Susanne, Heinrich, Luise, Kleinheinz, Andreas, Wollenberg, Andreas, Weisshaar, Elke, Schäkel, Kurt, Ertner, Konstantin, Wiemers, Franca, Wildberger, Julia, Worm, Margitta, von Kiedrowski, Ralph, Effendy, Isaak, Asmussen, Andrea, Augustin, Matthias, Pawlak, Mario, Sticherling, Michael, Zink, Alexander, Hilgers, Melanie, Handrick, Christiane, Quist, Sven R., Schwarz, Beate, Staubach-Renz, Petra, Bell, Magnus, Hong-Weldemann, Sun-Hei, Homey, Bernhard, Brücher, Jens Joachim, Schmitt, Jochen, Werfel, Thomas, and Weidinger, Stephan. “Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry”. Experimental Dermatology 31.2 (2022): E39-E40.
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Suchen in

Google Scholar